CIBC Private Wealth Group
ACHV icon

CIBC Private Wealth Group’s Achieve Life Sciences ACHV Stock Holding History

CIBC Private Wealth Group’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1
Closed – – 969
2018
Q2 		$0 Hold
1
– – ﹤0.01% 1942
2018
Q1 		$0 Buy
+1
New +$286 ﹤0.01% 1921

Other funds holding ACHV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

CIBC Private Wealth Group's ACHV Position: Q3 2018 in Review

CIBC Private Wealth Group sold out of Achieve Life Sciences (ACHV) in Q3 2018, closing a stake of 1 share.

CIBC Private Wealth Group first reported a position in ACHV in Q1 2018 and held it in 2 quarters. The position peaked at $0 in Q2 2018. 23 funds tracked by Wall St. Rank hold ACHV as of Q3 2018.

  • CIBC Private Wealth Group reported no remaining Achieve Life Sciences position as of Q3 2018 after selling out during the quarter.
  • CIBC Private Wealth Group sold 1 Achieve Life Sciences share in Q3 2018.
  • CIBC Private Wealth Group first reported a position in Achieve Life Sciences in Q1 2018 and held it in 2 quarters.
  • CIBC Private Wealth Group's Achieve Life Sciences position peaked at $0 in Q2 2018.
  • 23 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2018.

Based on CIBC Private Wealth Group's 13F filing for Q3 2018, filed 14 Nov 2018.